Research showed that S100A10 was selectively translocated to matrix vesicles of Saos-2 cells upon mineralization [72], whereas, in the context of cancer, S100A10 was shown to be linked to tumor progression [73]. The gene discussed is S100A10; the disease is neoplasm.